Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

DIODOQUIN TAB 210MG 210 MG

DIIODOHYDROXYQUIN : 210 MG · DIN 01997769 · GLENWOOD LABORATORIES CANADA LTD.

Health Canada status: CANCELLED POST MARKET

What is DIODOQUIN TAB 210MG?

DIODOQUIN TAB 210MG 210 MG contains DIIODOHYDROXYQUIN : 210 MG. It is listed in the Health Canada Drug Product Database under DIN 01997769, held by GLENWOOD LABORATORIES CANADA LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 18-Jun-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN01997769
Brand nameDIODOQUIN TAB 210MG
Generic / active ingredientDIIODOHYDROXYQUIN : 210 MG
ManufacturerGLENWOOD LABORATORIES CANADA LTD.
Strength210 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeP01AA HYDROXYQUINOLINE DERIVATIVES
AHFS class08:30.04
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date18-Jun-2015
Original market date1992-12-31 00:00:00

What can be used instead?

Other Canadian products sharing ATC code P01AA HYDROXYQUINOLINE DERIVATIVES. 0 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
DIODOQUIN TAB 650MG650 MGTABLETGLENWOOD LABORATORIES CANADA LTD.CANCELLED POST MARKETDIN 01997750

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for DIODOQUIN TAB 210MG

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for DIODOQUIN TAB 210MG

Health Canada Drug Product Database (DPD), DIN 01997769. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.